Color Discrimination in Patients with Gaucher Disease and Parkinson Disease

被引:2
|
作者
Simon-Tov, Shlomi [1 ]
Dinur, Tama [1 ]
Giladi, Nir [2 ]
Bar-Shira, Anat [2 ]
Zelis, Mayaan [2 ]
Zimran, Ari [1 ]
Elstein, Deborah [1 ]
机构
[1] Hadassah Hebrew Univ, Sch Med, Gaucher Clin, Shaare Zedek Med Ctr, Jerusalem, Israel
[2] Tel Aviv Univ, Sagol Sch Neurosci, Sackler Sch Med, IL-69978 Tel Aviv, Israel
关键词
GLUCOCEREBROSIDASE MUTATIONS; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; PERFORMANCE; DEFICITS; CARRIERS; ABNORMALITIES; PHENOTYPE; VISION; ONSET;
D O I
10.3233/JPD-150585
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Poor color discrimination among patients with Parkinson disease (PD) has long been recognized. It has been shown that carrying one or two mutations in the beta-glucocerebrosidase gene (GBA) for the autosomal disease Gaucher disease (GD), as based initially on clinical evidence, is a genetic risk factor for early-onset PD. Objective: The purpose of this study was to assess color discrimination in patients with one or two GBA mutations relative to healthy controls to ascertain whether this function is affected when persons with GD or even one GBA mutation develop PD. Methods: The Farnsworth-Munsell 100 hue test (FMHT) was evaluated among patients with GD+PD compared to patients with GD only, obligate GBA carriers with and without PD, patients with PD only, and healthy controls. FMHT outcome include computer-generated TES (Total Error Score) and values recommended by Vingrys & King-Smith. Results: Six groups of 10 persons were tested. Significant differences were seen for male GD+PD and for age in PD. The highest mean TES was in the PD only group, the lowest in the GD only group. There was a significant difference because of PD in groups with GD and GBA carriers. GD+PD means were between GD only and PD only mean scores. Conclusions: These findings confirm that PD impacts color discrimination, more in males with GD+PD but nonetheless, GD+PD patients (but not GBA carriers) had better scores than PD only patients.
引用
收藏
页码:525 / 531
页数:7
相关论文
共 50 条
  • [21] Parkinson's disease in Gaucher disease patients: what's changing in the counseling and management of patients and their relatives?
    Di Rocco, Maja
    Di Fonzo, Alessio
    Barbato, Antonio
    Cappellini, Maria Domenica
    Carubbi, Francesca
    Giona, Fiorina
    Giuffrida, Gaetano
    Linari, Silvia
    Pession, Andrea
    Quarta, Antonella
    Scarpa, Maurizio
    Spada, Marco
    Strisciuglio, Pietro
    Andria, Generoso
    ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)
  • [22] Parkinson’s disease in Gaucher disease patients: what’s changing in the counseling and management of patients and their relatives?
    Maja Di Rocco
    Alessio Di Fonzo
    Antonio Barbato
    Maria Domenica Cappellini
    Francesca Carubbi
    Fiorina Giona
    Gaetano Giuffrida
    Silvia Linari
    Andrea Pession
    Antonella Quarta
    Maurizio Scarpa
    Marco Spada
    Pietro Strisciuglio
    Generoso Andria
    Orphanet Journal of Rare Diseases, 15
  • [23] Gaucher disease provides a unique window into Parkinson disease pathogenesis
    Hertz, Ellen
    Chen, Yu
    Sidransky, Ellen
    NATURE REVIEWS NEUROLOGY, 2024, 20 (09) : 526 - 540
  • [24] The connection between UPR, Gaucher disease and Parkinson's disease
    Maor, G.
    Segal, D.
    Steller, H.
    Horowitz, M.
    MOLECULAR BIOLOGY OF THE CELL, 2013, 24
  • [25] Amyloid deposition in a patient with the complex Gaucher disease/Parkinson disease
    Lucas-Del-Pozo, Sara
    Moreno-Martinez, David
    Molto-Abad, Marc
    Tigri-Santina, Ariadna
    Lorenzo-Bosquet, Carles
    Hernandez-Vara, Jorge
    Pintos-Morell, Guillem
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S102 - S102
  • [26] Bone disease in patients with Gaucher disease
    Rosenbloom, Barry E.
    Weinreb, Neal J.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2014, 9 (02) : 153 - 162
  • [27] Prodromal Clinical Markers of Parkinson disease in Gaucher Disease Individuals
    Gatto, Emilia M.
    Etcheverry, Jose Luis
    Sanguinetti, Ana
    Cesarini, Martin
    Escobar, Nicolas Fernandez
    Drelichman, Guillermo
    EUROPEAN NEUROLOGY, 2016, 76 (1-2) : 19 - 21
  • [28] The connection between ERAD, UPR, Gaucher disease and Parkinson disease
    Horowitz, Mia
    Rencus-Lazar, Sigal
    Filocamo, Mirella
    Steller, Hermann
    Segal, Daniel
    Maor, Gali
    MOLECULAR GENETICS AND METABOLISM, 2014, 111 (02) : S55 - S55
  • [29] Gaucher's disease type 1 and Parkinson's disease
    Capus, LL
    Marsala, SSZ
    Zorzon, MM
    Gioulis, MM
    Martini, CC
    Bembi, BB
    MOVEMENT DISORDERS, 2002, 17 : S131 - S131
  • [30] Mutations for Gaucher Disease Confer High Susceptibility to Parkinson Disease
    Mitsui, Jun
    Mizuta, Ikuko
    Toyoda, Atsushi
    Ashida, Ryo
    Takahashi, Yuji
    Goto, Jun
    Fukuda, Yoko
    Date, Hidetoshi
    Iwata, Atsushi
    Yamamoto, Mitsutoshi
    Hattori, Nobutaka
    Murata, Miho
    Toda, Tatsushi
    Tsuji, Shoji
    ARCHIVES OF NEUROLOGY, 2009, 66 (05) : 571 - 576